BioSpace News Archive

Biotech Bay

AcelRx Pharmaceuticals Announces Publication of Clinical Data on Reduced Opioid Use and Reduced Time in the Postanesthesia Care Unit (PACU) Following Preoperative Administration of DSUVIA®

AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced the publication of a study entitled “Reduced Opioid Use and Reduced Time in the Postanesthesia Care Unit Following Pr

August 19, 2020
·
6 min read
Biotech Beach

TruMed® Systems, Inc. and OSIS Deploy AccuVax® NextGen Integration to Maximize Patient Safety for Immunizations and Save Staff Time

TruMed Systems and OSIS announced the release of the AccuVax-NextGen integration solution to current OSIS customers and not-for-profit NextGen users.

August 19, 2020
·
3 min read
Pharm Country

The Michael J. Fox Foundation Launches Virtual 5K/10K to Meet Ambitious Fundraising Goal and Unite the Parkinson’s Community

- Runners and walkers of all ages, abilities and speeds are encouraged to participate from anywhere in this remote event - Learn more and register at foxtrot.org -- 100 percent of registration fees go directly to the critical research programs of The Michael J. Fox Foundation [19-August-2020] NEW YORK , Aug. 19, 2020 /PRNewswire/ -- The Michael J. Fox Founda

August 19, 2020
·
3 min read
Pharm Country

Eyenovia, Inc. Prices Public Offering of Common Stock

Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP™) therapeutics, today announced the pricing of an underwritten public offering of 3,333,334 shares of its common stock at a price to the public of $3.60 per share

August 19, 2020
·
3 min read